Nisa Investment Advisors LLC Increases Stock Position in Cardinal Health, Inc. $CAH

Nisa Investment Advisors LLC boosted its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 56.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 122,864 shares of the company’s stock after acquiring an additional 44,307 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cardinal Health were worth $19,285,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. SJS Investment Consulting Inc. lifted its holdings in shares of Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its position in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares during the last quarter. Vermillion & White Wealth Management Group LLC lifted its stake in Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the period. NewSquare Capital LLC lifted its stake in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after acquiring an additional 107 shares during the period. Finally, AlphaCore Capital LLC purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at about $41,000. Institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Robert W. Baird set a $232.00 price objective on shares of Cardinal Health in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Evercore ISI increased their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. UBS Group lifted their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Finally, Leerink Partners increased their target price on Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a report on Monday, November 17th. Fourteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $212.60.

Read Our Latest Research Report on Cardinal Health

Cardinal Health Stock Down 0.7%

Shares of CAH opened at $201.06 on Friday. The business has a 50-day simple moving average of $204.05 and a two-hundred day simple moving average of $173.10. The stock has a market cap of $47.77 billion, a price-to-earnings ratio of 30.33, a PEG ratio of 1.47 and a beta of 0.65. Cardinal Health, Inc. has a 52 week low of $119.25 and a 52 week high of $214.93.

Cardinal Health (NYSE:CAHGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s quarterly revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.